Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia
Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia
Recruiting · NCT05827549 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-07-29 | NCT05827549 |
10 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |
| Chonnam National University Hwasun Hospital | Hwasun | South Korea | 16 |
| Chungnam National University Hospital | Daejeon | South Korea | 38 |
| Jeju National University Hospital | Jeju City | South Korea | 9 |
| Kyungpook National University Chilgok Hospital | Daegu | South Korea | 57 |
| Pusan National University Yangsan Hospital | Yangsan | South Korea | 30 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Seoul National University Hospital | Seoul | South Korea | 393 |
| Seoul saint Mary's Hospital | Seoul | South Korea | 4 |
| Severance Hospital | Seoul | South Korea | 81 |